SCHEMBL7420540

SCHEMBL7420540

CCn1ncc2c(NCc3ccc(O)cc3)c3ccccc3nc21

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.50
RAD52 P43351 1/20 0.50
KMT2A Q03164 1/20 0.50
PDE4B Q07343 2/20 0.45
PDE5A O76074 2/20 0.42
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
BACE1 P56817 1/20 0.40
PDE4D Q08499 2/20 0.40
NR3C1 P04150 1/20 0.39
PDE9A O76083 1/20 0.39
GFER P55789 1/20 0.39
ADORA1 P30542 2/20 0.39
ABL1 P00519 1/20 0.39
SRC P12931 1/20 0.39
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7028354 0.92 KMT2A (0.60) POLBRAD52KMT2APDE4BBCHE
SCHEMBL7422618 0.90 POLB (0.46) POLBRAD52KMT2APDE4BPDE5A
SCHEMBL7423097 0.89 POLB (0.48) POLBRAD52KMT2APDE4BPDE5A
SCHEMBL7420650 0.88 PDE5A (0.50) POLBRAD52KMT2APDE4BPDE5A
SCHEMBL7418635 0.87 POLB (0.51) POLBRAD52KMT2APDE4BPDE5A
SCHEMBL7416586 0.87 EGFR (0.52) POLBRAD52KMT2APDE5APDE9A
Hydrochloric Acid SCHEMBL7423114 0.86 EGFR (0.51) POLBRAD52KMT2APDE5APDE9A
SCHEMBL8444030 0.83 ALDH1A1 (0.50) POLBRAD52KMT2APDE5APDE9A
SCHEMBL7422887 0.82 ACHE (0.57) POLBRAD52KMT2APDE5ABCHE
SCHEMBL7419604 0.81 ACHE (0.53) POLBRAD52KMT2APDE4BPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6008226-A AN ENZYME INHIBITOR OF C-GMP-PHOSPHODIESTERASE FOR TREATING HEART FAILURE, HYPERTENSION, REVERSING OR REDUCING NITRATE-INDUCED TOLERANCE AND ANGINA PECTORIS, CONGESTIVE HEART DISEASE AND MYOCARDIAL INFARCTION SANOFI-SYNTHELABO (FR) 1999-12-28 US disclosed
US-5852035-A Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines CELL PATHWAYS, INC. (US) 1998-12-22 US disclosed
US-5843956-A Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo (3,4-b) quinolin-4-amines and compositions and methods of use thereof SANOFI (FR) 1998-12-01 US disclosed
US-5614530-A GMP PHOSPHODIESTERASE INHIBITOR, HYPOTENSIVE STERLING WINTHROP INC. (US) 1997-03-25 US disclosed
WO-1996028159-A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-09-19 WO disclosed